| abstract |
Compounds which function as melanocortin receptor ligands and having utility in the treatment of melanocortin receptor-based disorders. The compounds having the following structure (I): including stereoisomers, prodrugs, and pharmaceutically acceptable salts thereof, wherein A, n, R1, R2, R3a, R3b, R4, R5, R6 and R7 are as defined herein. Pharmaceutical compositions containing a compound of structure (I), as well as methods relating to the use thereof, are also disclosed. |